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1  | INTRODUC TION
Ballan wrasse (Labrus bergylta, Ascanius) is one of the main cleaner 
fish species used as a biological control in the salmon industry, 
to control sea lice (Lepeophtheirus salmonis Krøyer) infections of 
Atlantic salmon (Salmo salar Linnaeus). Atypical Aeromonas salmoni-
cida (aAs) is a highly heterogeneous bacterial species, and different 
strains infect fish in a host-specific manner (Gulla et al., 2019). The 
vapA type V and type VI strains are major bacterial pathogens of 
wild-caught and farmed ballan wrasse, and early detection of these 
strains could assist vaccine development for disease mitigation. The 
significance of the bacterium in wrasse disease outbreaks has been 
reported in Scotland and Ireland since the 1990s, where members 
of the family (e.g., Ctenolabrus rupestris and C. exoletus, L.) were 
used as cleaner fish for the first time (Frerchs et al., 1992; Treasurer 
& Cox, 1991; Treasurer & Laidler, 1994). In Norway, 32 cases of 
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Abstract
Aeromonas salmonicida (As) is a highly heterogeneous bacterial species, and strains’ 
host specificity has been reported. Ballan wrasse (Labrus bergylta Ascanius, 1767) 
is susceptible to atypical As (aAs) vapA type V and type VI in Scotland and Norway. 
Identification of the bacterium is achieved by culture and molecular techniques; how-
ever, the available methods used to distinguish the As types are costly and time-
consuming. This paper describes the development of a PCR and a restriction enzyme 
assay for the detection of aAs vapA type V and type VI in ballan wrasse, respectively. 
Type V-specific primers were designed on conserved regions of the vapA gene, and 
the restriction enzyme assay was performed on the PCR products of the hypervari-
able region of vapA gene for the detection of type VI isolates. Amplification product 
was produced for type V (254 bp) and restriction bands (368 and 254 bp) for type VI 
isolates only. In addition, the assays detected type V and type VI isolates in spiked 
water samples and type V in diagnostic tissue samples. The assays are fast, specific 
and cost-effective and can be used as specific diagnostic tools for cleaner fish, to de-
tect infectious divergence strains, and to manage and mitigate aAs disease outbreaks 
through vaccine development.
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reaction
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atypical furunculosis were related to aAs infection in ballan wrasse 
in 2015, although reports of outbreaks have declined by nearly half 
between 2016 and 2018 (Hjeltnes et al., 2019). However, a previous 
study reported aAs as the most prevalent bacterial species isolated 
from ballan wrasse (farmed and wild) in Scotland (Hewson, 2019). 
The transmission of aAs from ballan wrasse to farmed Atlantic 
salmon (S. salar) has not been reported, presumably resulting from 
immunization of Atlantic salmon prior to transfer to the sea or that 
the species is not susceptible to the two cleaner fish-associated aAs 
types (V and VI) (Brooker et al., 2018; Evensen, 2016; Sommerset 
et al., 2005). Authorized antimicrobial treatments are being used 
to treat clinical outbreaks in cleaner fish when necessary (Brooker 
et al., 2018); however, concerns regarding welfare (e.g., stress re-
lated to handling) and antibiotic resistance (Watts et al., 2017) mean 
that the development of a vaccine for cleaner fish is of particular 
importance (Brooker et al., 2018).
Aeromonas salmonicida was first reported as Bacillus salmonicida 
in Germany (Emmerich & Weibel, 1894) as the causative agent of 
a disease affecting brown trout (Salmo trutta, L.), prior to reclassifi-
cation into the genus Aeromonas (Griffin et al., 1953). Five subspe-
cies have been described for As including salmonicida (Lehmann & 
Neumann, 1896; Schubert, 1967), achromogenes (Schubert, 1967; 
Smith, 1963), masoucida (Kimura, 1969a, 1969b), smithia (Austin 
et al., 1989) and pectinolytica (Austin & Austin, 2016; Holt et al., 1994; 
Pavan et al., 2000). In early years, the misconception that salmonids 
are predominantly susceptible to the bacterium led to the establish-
ment of the term “typical” for a homogenous group of isolates (A. sal-
monicida subsp. salmonicida) causing furunculosis disease to salmonids 
and atypical for heterogeneous isolates, which infected predominantly 
nonsalmonid species and/or were phenotypically or biochemically dif-
ferent from subsp. salmonicida (McCarthy & Roberts, 1980). Although 
the classification of the atypical isolates was achieved, to some extent, 
with partial sequencing techniques in the past years (Beaz-Hidalgo 
et al., 2008; Kwon et al., 1997; Livesley et al., 1999; Lund et al., 2002; 
O'HIci et al., 2000), contrasting results were often found, and there-
fore, a more reliable diagnostic method was needed.
A virulence factor, the paracrystalline surface array protein (known 
as A-layer protein), has successfully been used for the differentia-
tion of typical and atypical As strains (Gulla, Lund, et al., 2016; Gulla 
et al., 2019). This additional outer membrane protein plays an import-
ant role in host infection and providing protection for the bacterium by 
resisting host immune responses (Daly et al., 1996; Kay & Trust, 1991; 
Munn et al., 1982; Udey & Fryer, 1978). Lund and Mikkelsen (2004) 
reported defined groups for atypical isolates by sequencing the vapA 
gene, which encodes the A-layer protein. Subsequently, sequencing of 
the hypervariable region of the vapA gene enabled the allocation of 
23 vapA types and most of them were host-specific (Gulla et al., 2019; 
Gulla, Lund, et al., 2016). Ballan wrasse is susceptible to As type V, 
predominant in Scotland, and type VI mainly in Norway (Gulla, Duodu, 
et al., 2016; Papadopoulou et al., 2020).
Several techniques have been developed for the identification of 
the bacterium during a disease outbreak including culture (Austin & 
Austin, 2016; Cipriano & Austin, 2011), serological (e.g., ELISA, IFAT) 
(Adams et al., 1995; Austin et al., 1989; Kawahara & Kusuda, 1987) 
and molecular assays (e.g. Gulla, Duodu, et al., 2016; Hiney et al., 1992; 
Livesley et al., 1999). Traditionally, isolation of As was achieved by cul-
ture, frequently on tryptone soya agar (TSA), blood agar (BA) or brain 
heart infusion agar (BHIA), where typical isolates produce the charac-
teristic brown pigment (TSA only) (Cipriano & Austin, 2011). Difficulties 
in isolating the bacterium from carrier fish, the relatively slow growth 
of the bacterium on agar plates which can result in false-negative out-
comes and the need for a quick screening tool led to the development 
of a number of conventional or quantitative polymerase chain reac-
tion (PCR or qPCR) assays for As detection (e.g. Balcazar et al., 2007; 
Beaz-Hidalgo et al., 2008; Byers, Cipriano, et al., 2002; Byers, Gudkovs, 
et al., 2002; Gulla, Duodu, et al., 2016; Gustafson et al., 1992; 
Hiney et al., 1992; Keeling et al., 2013; Miyata et al., 1996; O'Brien 
et al., 1994; Rattanachaikunsopon & Phumkhachorn, 2012). Although 
very sensitive, the above methods cannot distinguish As at the strain 
type level, which is important for disease control during an outbreak.
The current paper describes the development of two novel, fast, 
specific and low-cost assays for the detection of aAs type V and type 
VI in ballan wrasse. The assays can be used as a screening tool during 
disease outbreaks, to detect infectious strains and trace strain diver-
gence, thus providing health certification and isolate identification 
for vaccine development.
2  | MATERIAL S AND METHODS
2.1 | Bacterial cultivation
Representative As strains, unrelated bacteria and commonly isolated 
bacteria from ballan wrasse were used for the assessment of the 
TA B L E  1   List of bacterial species used for specificity testing 
on newly designed As vapA type V primers and restriction enzyme 
assay for the detection of type VI in ballan wrasse samples
Species Strain ID
Aeromonas salmonicida subsp. salmonicida NCIMB 1102b 
atypical Aeromonas salmonicidaa  ORN6
atypical Aeromonas salmonicida (type VI)a  SAIC-CF-026
atypical Aeromonas salmonicida (type V)a  SAIC-CF-019
atypical Aeromonas salmonicida (type VI)a  SAIC-CF-035
Aeromonas salmonicida subsp. achromogenes NCIMB 1110b 
Vibrio (Listonella) anguillarum NCIMB 6b 
Vibrio ordalii NCIMB 2167b 
Vibrio splendidus ATCC® 33125b 
Pasteurella skyensisa  LN-45 XG
Pseudomonas anguilliseptica NCIMB 2185
Abbreviations: ATCC, American Type Culture Collection; NCIMB, 
National Collection of Industrial Food and Marine Bacteria; SAIC-CF, 
Cleaner fish bacterial culture collection in Aquatic Vaccine Unit.
aInstitute of Aquaculture bacterial culture collection. 
bType strain. 
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newly developed assays. A list of the bacteria used in the study is 
provided in Table 1. Aeromonas salmonicida and Pseudomonas anguil-
liseptica isolates were plated on tryptone soya agar TSA (Oxoid), while 
Vibrionaceae isolates were cultured on seawater agar (SWA; Oxoid) 
and incubated at 22°C for 48 and 24 hr, respectively. Pasteurella sky-
ensis was cultured on BA (TSA + 5% sheep blood, Thermo Fisher) 
at 22°C for 48 hr. The bacteria were then inoculated onto tryptone 
soya broth (TSB; Oxoid, UK; As isolates) and TSB + 2% NaCl (Oxoid, 
Vibrionaceae isolates) and incubated at 22°C for 48 hr and 24 hr, re-
spectively, with continuous shaking at 150 rpm. All bacteria were cen-
trifuged at 2,000 g for 10 min, and bacterial pellets were then washed 
with phosphate-buffered saline (PBS) and resuspended in PBS to an 
optical density (OD) of OD600 ~ 1.0. The bacterial colony-forming 
units (CFUs) per ml were counted by the 10-fold dilution method.
2.2 | DNA extraction
Bacterial DNA was extracted using a modified salt precipitation pro-
tocol (Aljanabi & Martinez, 1997) as described in Taslima et al. (2016). 
The samples were resuspended in 5 mM Tris, and sample concentra-
tion was measured and standardized at 50 ng/μl using NanoDrop 
1000 (NanoDrop Technologies). The samples were stored at −20°C 
until use.
2.3 | aAs vapA type V assay design
An atypical As type V PCR was developed and used in order to 
determine the presence or absence of type V isolates in ballan 
wrasse samples. Gulla, Lund, et al. (2016) sequenced the hyper-
variable region of the additional outer membrane of As—the par-
acrystalline surface protein (A-layer protein) gene (vapA)—and 
identified 14 different types. In total, 71 vapA gene sequences 
were downloaded representing the 14 different types identi-
fied from the GenBank database (Table S1). The sequences were 
aligned using ClustalW in BioEdit (Hall, 1999), and conserved re-
gions for As type V within the vapA gene were identified as po-
tential primer sites with Aeromonas salmonicida type V primers 
specific to these locations being designed using Primer-BLAST suit 
(https://www.ncbi.nlm.nih.gov/tools/ prime r-blast/). The primers 
were screened for primer specificity (species-specific), in an in sil-
ico analysis using local nucleotide alignment tool “BLAST” (https://
blast.ncbi.nlm.nih.gov/Blast.cgi) (Ye et al., 2012). The primers se-
lected, Vspec—F: 5′-CCAACGGTTTCTGGAGTAATAACTTT-3′ and 
Vspec—R: 5′-TGCATCAGCAAC AGCGGTAGT-3′, were tested using 
routine PCRs consisting of 25 ng bacterial DNA (0.5 μl) from type 
strain As (ATCC 1102), 10 μM (0.25 μl) of each primer, 1 × Q5® Hot 
Start High-Fidelity Master Mix (2×) (NEB Biolabs), 10 mM dNTPs 
(2.5 μl), 1 × Q5 High GC Enhancer (1 μl) and Milli-Q water to reach 
5 μl total volume. Following optimization, the following thermal 
cycling conditions were used: 1 cycle at 98°C for 1 min, 30 cycles 
at 95°C for 15 s, 57°C for 15 s and 72°C for 15 s, followed by 1 
cycle at 72°C for 2 min and cooling at 4°C. PCR assay products 
were visualized using gel electrophoresis to confirm the presence 
of aAs type V in the sample; single product at 254 base pairs (bp) 
indicates the presence of aAs type V.
2.4 | Design of restriction enzyme assay for aAs 
vapA type VI
Initially, the vapA gene was amplified using a previous protocol (Gulla, 
Lund, et al., 2016) and the obtained products (1 μl out of 5 μl) were 
digested with the restriction enzyme ScaI (cut site 5′-AGT▼ACT-3′, 
New England Biolabs®) at a final volume of 5 μl for 1 hr at 37°C ac-
cording to conditions specified by the manufacturer. Restriction 
products (5 μl of enzyme digest) were visualized by gel electrophore-
sis to determine whether no product was present (no aAs present in 
sample), a single band of 625 bp was present (aAs other than type VI 
present in sample) or two bands of 368 bp and 254 bp were present 
(aAs type VI present in sample).
2.5 | Assay analytical specificity and relative 
sensitivity
The specificity of aAs vapA type V PCR and restriction enzyme assay 
(type VI) was tested against DNA of target and non-target bacterial 
species at 50 ng/μl (from active cultures of approx. 107 and 108 CFU/
ml, for As and Vibrionaceae or Pasteurella skyensis) (Table 1). Initially, 
all bacterial DNAs were screened with a broad-range 16S rRNA 
PCR for the detection of bacterial DNA as described previously 
(Herlemann et al., 2011), and with vapA PCR (Gulla, Lund, et al., 2016) 
during which only As samples were expected to be amplified. Finally, 
all samples were screened with the newly developed aAs type V and 
type VI assays described above. PCR and restriction enzyme prod-
ucts were sequenced (GATC Eurofins) following enzymatic cleanup 
where 5 μl of PCR product was mixed with 1 μl of exonuclease (New 
England Biolabs®) and 1 μl of shrimp alkaline phosphatase (New 
England Biolabs®) and digested in accordance with manufacturer's 
guidelines (Exo-CIP Rapid PCR Cleanup Kit, New England Biolabs®).
The relative sensitivity of the assays was assessed on water (ster-
ile and tap water; 25 and 15 ml) spiked with aAs vapA type V and 
type VI at an OD600 1.0 (10
7 CFU/ml) and two liver samples from 
naturally infected individuals that had previously been confirmed to 
be positive for aAs vapA type V by sequencing. The water samples 
were centrifuged at 5,100 g for 10 min, and the supernatant was re-
moved prior to DNA extraction. The DNA was extracted from water 
and tissues samples with the method described earlier. The total aAs 
concentration in the undiluted extracted DNA (600 ng/μl) from liver 
samples was approximately 104 CFU/ml (crossing point; Cp 28.58) 
and 107 CFU/ml (Cp 22.53) using a previously published qPCR to 
quantify (Gulla, Duodu, et al., 2016). Various concentrations were 
prepared for the two liver DNA samples (10, 25, 50, 100 and 600 ng/
μl) in order to determine the appropriate screening concentration.
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2.6 | Diagnostic validation of assays
Whole ballan wrasse larvae and tissue samples (liver-L and head 
kidney-HK) were collected randomly from healthy-looking individu-
als from a commercial ballan wrasse hatchery in Scotland between 
February and September in the same production year. The hatch-
ery had a history of aAs outbreaks in the previous years. A total of 
140 whole larvae samples (various sizes from 2 to approx. 120 days 
post-hatch; dph, 20 samples/month; 10 newly hatch/live prey feed-
ing larvae and 10 weaned larvae) and 120 tissue samples (60 liver 
and 60 head kidney various sizes ≥ 120 dph to 15 months old/pre-
deployment) were gathered and fixed in 100% ethanol and stored 
at 4°C for later use. DNA was extracted from samples of 1–2 mm 
long and 1 mm thick using the protocol described previously. From 
those, 70 whole fish and 120 liver and head kidney (60 each) were 
screened with the assays developed above using 50 ng of total ex-
tracted DNA. The above samples were also screened with a qPCR 
protocol for As bacterial loads designed on vapA gene (Gulla, Duodu, 
et al., 2016) for cross-validation.
3  | RESULTS
All bacterial strains used for the validation of the newly design as-
says were screened with a generic 16S PCR (Figure 1). Samples were 
then screened with vapA PCR (Gulla, Lund, et al., 2016), and only As 
samples were amplified (Figure 2). The newly designed primers for 
aAs vapA type V PCR and restriction enzyme assay (type VI) yielded 
the expected products of 254 bp, and 368 and 254 bp, respectively 
(Figures 3 and 4). The amplification products were sequenced and 
the sequences confirmed to have 100% identity to As vapA gene by 
BLAST and type V and type VI following sequence alignment using 
ClustalW. PCR products were reported only for aAs vapA type V and 
type VI isolates, as is shown in Figures 3 and 4, resulting in 100% spec-
ificity for the bacteria tested herein. The assays were able to detect 
aAs vapA type V and type VI in water samples (sterile and tap water) 
spiked with aAs vapA type V and type VI isolates (Figures 5 and 6).
Liver tissues naturally infected with aAs vapA type V tested pos-
itive with the newly developed PCR assay for the majority of the 
concentrations tested (25, 50, 100 and 600 ng/μl) apart from the 
10 ng/μl (Figures 7 and 8). However, based on the electrophoresis 
results, a concentration of 100 ng/μl would be appropriate for the 
screening of diagnostic samples to avoid false-positive results.
A total of 16 diagnostic samples (4/70 larvae, 8/60 L and 4/60 
HK) randomly collected from apparently healthy individuals from 
commercial ballan wrasse tested positive with type V-specific PCR. 
Matching positive results were observed for the liver and kidney 
samples for two individuals. None of the diagnostic samples were 
positive for aAs vapA type VI, apart from the positive control aAs 
vapA type VI sample, which was amplified successfully. In addition, 
the same samples screened with a previously developed qPCR for 
As and 17 positive samples were identified (4/70 larvae, 8/60 L and 
5/60 HK) 16 of which were in corroboration with the diagnostic PCR 
assay for aAs vapA type V. These samples had medium (8/17)-to-
low (9/17) bacterial loads corresponding to Cp value ≥25–30 and 
≥31–35, respectively.
4  | DISCUSSION
Atypical Aeromonas salmonicida are commonly isolated bacteria 
from morbid ballan wrasse during bacterial disease outbreaks in the 
Northern Hemisphere (Hewson, 2019; Hjeltnes et al., 2019; Laidler 
et al., 1999). This fish species is susceptible to two aAs vapA types 
(V and VI) (Gulla, Lund, et al., 2016). Type-specific diagnosis of aAs 
can help in controlling the disease spread in ballan wrasse hatcheries 
and Atlantic salmon cage sites following deployment as cleaner fish. 
In this paper, we describe the development of two rapid, specific and 
low-cost assays for the detection of aAs vapA type V and type VI in 
ballan wrasse.
A number of molecular assays (PCR and qPCR) are available for 
the detection of As. In particular, qPCR assays are highly sensitive and 
specific (Beaz-Hidalgo et al., 2008; Byers, Cipriano, et al., 2002; Gulla, 
Duodu, et al., 2016; Gustafson et al., 1992; Rattanachaikunsopon 
& Phumkhachorn, 2012). However, they require custom-designed 
probes, that is self-quenched primers and molecular beacons, which 
are costly (e.g., $200/500 samples). Furthermore, existing molecu-
lar assays are only able to detect As DNA at the broader species 
F I G U R E  1   Agarose gel (1%) analysis for bacterial presence with 16S PCR on DNA extracted from a variety of bacterial species at 50 ng/
μl. From left to right 100-bp ladder (GeneRuler, Thermo Fisher Scientific; lanes 1 and 12), Vibrio anguillarum (lane 2), Vibrio ordalii (lane 3), 
Vibrio splendidus (lane 4), Aeromonas salmonicida subsp. salmonicida (lane 5), Aeromonas salmonicida subsp. achromogens (lane 6), atypical 
Aeromonas salmonicida (aAs) (lane 7), aAs type IV (lane 8), Pasteurella skyensis (lane 9), aAs type V (lane 10) and no template control (lane 11). 
PCR product is of the expected size of 485 bp. PCRs were standardized for DNA samples at 25 ng
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level but cannot differentiate type strains. Such information pre-
viously depended on isolate sequencing techniques (Gulla, Lund, 
et al., 2016), which are time-consuming, expensive and require 
specialized technical understanding, in contrast with the conven-
tional PCR and restriction enzyme assay described in this paper (e.g., 
$60/500 samples).
F I G U R E  2   Agarose gel (1%) analysis for atypical Aeromonas salmonicida (aAs) presence with vapA PCR (Gulla, Lund, et al., 2016) on 
DNA extracted from a variety of bacterial species at 50 ng/μl. From left to right 100-bp ladder (GeneRuler, Thermo Fisher Scientific; lanes 
1 and 12), Vibrio anguillarum (lane 2), Vibrio ordalii (lane 3), Vibrio splendidus (lane 4), Aeromonas salmonicida subsp. salmonicida (lane 5), 
Aeromonas salmonicida subsp. achromogens (lane 6), atypical Aeromonas salmonicicda (aAs) (lane 7), aAs type IV (lane 8), Pasteurella skyensis 
(lane 9), positive control aAs type V (lane 10) and no template control (lane 11). PCR product is of the expected size of 625 bp. PCRs were 
standardized for DNA samples at 25 ng
F I G U R E  3   Specificity test for atypical Aeromonas salmonicida (aAs) vapA type V newly designed primers on DNA samples extracted from 
a variety of bacterial species at 50 ng/μl. Samples run on an agarose gel (1%). From left to right 100-bp ladder (GeneRuler, Thermo Fisher 
Scientific; lanes 1 and 12), Vibrio anguillarum (lane 2), Vibrio ordalii (lane 3), Vibrio splendidus (lane 4), Aeromonas salmonicida subsp. salmonicida 
(lane 5), Aeromonas salmonicida subsp. achromogenes (lane 6), atypical Aeromonas salmonicida (aAs) (lane 7), aAs type IV (lane 8), Pasteurella 
skyensis (lane 9), aAs vapA type V (lane 10) and no template control (lane 11). PCR product is of the expected size of 254 bp. PCRs were 
standardized for DNA samples at 25 ng
F I G U R E  4   Specificity test for restriction enzyme assay on DNA samples extracted from a variety of bacterial species at 50 ng/μl. Isolated 
bacteria were screened with a broad-spectrum PCR for atypical Aeromonas salmonicida (aAs) based on the vapA region; samples in lanes 2–7 
(Gulla, Lund, et al., 2016) and PCR products restricted with ScaI (New England Biolabs®) in lanes 9–14. Samples run on agarose gel (1%). From 
left to right 100-bp ladder (GeneRuler, Thermo Fisher Scientific; 1, 8 and 15), Aeromonas salmonicida sub. salmonicida (lanes 2 and 9), aAs 
vapA type VI (lanes 3 and 10), aAs vapA type V (lanes 4 and 11), aAs vapA (lanes 5 and 12), aAs vapA type V (lanes 6 and 13) and no template 
control (lanes 7 and 14). PCR products are of the expected size of 625 bp and two bands for restriction enzyme at 368 and 254 bp. PCRs 
were standardized for DNA samples at 25 ng
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Several genes have been targeted for the diagnosis of As over the 
years including the vapA gene (Austin & Austin, 2016). This gene is 
one of the most preferable genes for molecular assay development 
as it encodes the outer membrane A-layer protein of the bacterium 
and has a significant role in its virulence (Daly et al., 1996; Udey & 
Fryer, 1978). In this study, both type-specific (V and VI) assays were 
designed based on the vapA gene. The assays have 100% specificity 
and did not cross-react with other Aeromonas subspecies, for exam-
ple achromogens or atypical isolates and other bacteria that were 
tested (e.g., Vibrio anguillarum, Vibrio splendidus, Pasteurella skyensis), 
which are commonly isolated in cleaner fish (Hewson, 2019; Hjeltnes 
et al., 2019). Two closely related bacteria As subsp. pectinolytica and 
A. hydrophila were not included in the specificity test because the 
former has not been recovered in fish (Merino et al., 2015; Pavan 
et al., 2000), while the latter is mainly isolated in freshwater species 
(Austin & Austin, 2016). Nevertheless, the amplification products for 
the type V and type VI assays developed herein were sequenced and 
screened in silico (BLAST) against A. hydrophila and all the other four 
As subspecies (achromogenes, masoucida, smithia and pectinolytica) 
F I G U R E  5   Agarose gel (1%) analysis for atypical Aeromonas salmonicida (aAs) vapA type V assay. Sensitivity and specificity on bacterial 
DNA isolated from sterile or tap water spiked with aAs type V or type VI (1 ml bacteria at 107 CFU/ml) after centrifugation. From left to right 
100-bp ladder (GeneRuler, Thermo Fisher Scientific; lanes 1 and 16), tap water spiked with aAs vapA type V (lane 2), tap water spiked with 
aAs vapA type VI at 107 CFU/ml (lanes 3 and 7), sterile water (25 ml) spiked with aAs vapA type V at 107 CFU/ml (lane 4) and DNA diluted 
1/10 (lane 5) and 1/100 (lane 6), positive control aAs vapA type V (lane 8) and no template control (lane 9). Positions 10 to 15 empty. PCR 
product is of the expected size of 254 bp. PCRs were standardized for DNA samples at 25 ng
F I G U R E  6   Agarose gel analysis for atypical Aeromonas 
salmonicida (aAs) vapA type VI assay. Sensitivity and specificity on 
bacterial DNA isolated from 15-ml tap water spiked with aAs type 
V or type VI (1 ml bacteria at 107 CFU/ml) after centrifugation. 
From left to right 100-bp ladder (lanes 1 and 8), tap water spiked 
with aAs vapA type VI (lane 2), tap water spiked with aAs vapA type 
V (lanes 3 and 5), positive control aAs vapA type VI (lane 4) and no 
template control (lane 6). Position 7 empty. PCR product is of the 
expected size of 368 and 254 bp. PCRs were standardized for DNA 
samples at 25 ng
F I G U R E  7   Ballan wrasse liver samples (n = 2) naturally infected with atypical Aeromonas salmonicida (aAs) vapA type V at various 
concentrations (in duplicate 10, 25, 50, 100 and undiluted DNA; 600 ng/μl). Samples screened with the Aeromonas salmonicida vapA region 
PCR (Gulla, Lund, et al., 2016) and run on 1% agarose gel. Samples from left to right; 100-bp ladder (lane 1), DNA extracted from two liver 
samples of a concentration at 10 ng/μl (lanes 2 and 3), 25 ng/μl (lanes 4 and 5), 50 ng/μl (lanes 6 and 7), 100 ng/μl (lanes 8 and 9) and 600 ng/
μl (lanes 10 and 11). Positive control: aAs vapA type V and type VI (lanes 12 and 13, respectively), negative control: Pseudomonas sp. (lane 14), 
ballan wrasse genomic DNA (lane 15) and no template control (lane 16). PCRs were standardized for DNA samples at 25 ng
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with there being no identity to registered sequences. In addition, all 
the other available As vapA types were also aligned in silico for assay 
specificity assessment. The primer sites for type V and restriction 
site for type VI are in conserved regions of the vapA gene and are 
not cross-reactive with the other types. The newly designed prim-
ers successfully identified the aAs vapA type V in diagnostic sam-
ples (liver and kidney samples), while type VI bacterial DNA was 
detected only within the positive control sample and not in the di-
agnostic samples. In addition, the same samples were positive when 
tested with the previously published qPCR assay (Gulla, Duodu, 
et al., 2016), with the exception of one additional positive kidney 
samples. This sample had a very high Cp value (34) and subsequently 
very low bacterial load. The qPCR used for cross-validation of the 
newly developed assays is a molecular beacon probe assay (Gulla, 
Duodu, et al., 2016). Molecular beacons are highly specific and more 
sensitive (i.e. lower detection limits) than conventional PCRs (Gulla, 
Duodu, et al., 2016; Manganelli et al., 2001), which explains the de-
tection of these samples with low bacterial load with the qPCR and 
not the newly developed assays. The absence of positive aAs vapA 
type VI is in corroboration with the previous report of rare isolation 
of this type in ballan wrasse in Scotland (Papadopoulou et al., 2020). 
The samples were screened at total DNA concentrations of 100 ng/
μl to eliminate false-positive results; however, the relative sensitiv-
ity test demonstrated that samples could be screened at lower con-
centrations of 25 ng/μl. The sensitivity of the assays can be further 
optimized in order to increase the sensitivity (e.g., PCR cycles, sam-
ple concentration), if required. The diagnostic tools described in this 
study may also be used for lumpsucker (Cyclopterus lumpus, L.) tissue 
screening, as they are susceptible to aAs (Hjeltnes et al., 2019), al-
though validation will be required.
The positive results on type V and type VI spiked water samples 
support the potential use of the molecular assays for monitoring pur-
poses in hatchery sites. In general, Aeromonas salmonicida isolation 
from environmental samples has been attempted on solid medium 
cultivation methods in the past with not encouraging results (Du 
et al., 2017; Teska & Cipriano, 1993). The bacterium is difficult to re-
cover from these samples where mixed bacterial communities co-ex-
ist due to the lack of selective media and overgrowth of concomitant 
bacteria. Furthermore, diagnostics can be difficult where a change 
in physiological status (i.e., dormancy) of As occurs outside of the 
host—that is where it is still viable but not culturable (Popoff, 1984; 
Stevenson, 1977). All the above are strongly supporting that the use 
of molecular techniques like the ones developed herein is important 
for pathogen detection to control a disease outbreak in a commercial 
site.
In conclusion, we described the development of two novel 
type-specific assays for aAs (type V and type VI) detection in ballan 
wrasse. The assays are fast, reliable, cost-effective and easy to per-
form. They can be applied as screening tools in disease outbreaks 
and health certification (e.g., transportation from hatchery to cage 
sites) for cleaner fish. They can also be used to facilitate autogenous 
vaccine development and vaccine trials for isolate confirmation at 
the type level (Papadopoulou et al., 2020). Future studies are re-
quired to optimize the assays for environmental samples (i.e., water 
samples) and screening of other cleaner fish species (i.e., lumpsucker 
samples). Furthermore, modification of the newly developed assays 
described in this paper for the development of qPCR assays could 
provide information on bacterial load at the type level in cleaner fish 
samples.
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F I G U R E  8   Assay sensitivity test on atypical Aeromonas salmonicida (aAs) vapA type V primer set for two liver samples of ballan wrasse 
naturally infected with aAs vapA type V. Total extracted DNA samples adjusted and tested at various concentrations (in duplicate 10, 25, 50, 
100 and neat; 600 ng/μl). Samples run on 1% agarose gel from left to right; 100-bp ladder (GeneRuler, Thermo Fisher Scientific; lane 1), DNA 
extracted from 2 liver sample concentration at 10 ng/μl (lanes 2 and 3), 25 ng/μl (lanes 4 and 5), 50 ng/μl (lanes 6 and 7), 100 ng/μl (lanes 
8 and 9) and 600 ng/μl (lanes 10 and 11). Positive control: aAs vapA type V and type VI (lanes 12 and 13, respectively), negative control: 
Pseudomonas sp. (lane 14), ballan wrasse genomic DNA (lane 15) and no template control (lane 16). PCR product is of the size of 254 bp, as 
expected. Notice the negative PCR amplification (no band on gel) for aAs vapA type VI samples. PCRs were standardized for DNA samples at 
25 ng
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